Well Woman

Learn how early detection, patient education, and personalized risk assessments can help ob-gyns support women in reducing the impact of breast cancer.

Reunion Neuroscience is enrolling patients in its phase 2 RECONNECT trial to assess a single-dose synthetic psychedelic to treat the depressive symptoms of PPD.

In this 4-part interview, Kingsberg discusses the phase 2 RECONNECT trial assessing RE104 as the potentially first psychedelic to treat postpartum depression.

A new study shows that breast arterial calcification detected on routine mammograms could help predict cardiovascular events such as heart attacks and strokes, particularly in younger women.

Erika Hamilton, MD, discusses concerning increases in breast cancer incidence among younger women and certain ethnic groups, while highlighting new innovations in detection and targeted therapies that offer hope for improved patient outcomes.

From screening, to workup and treatment, find out how to provide the best course of action for your pregnant patients with anemia.

In a recent study, approximately half of infective endocarditis cases were women who inject drugs, despite only one-third of people who inject drugs being women.

In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.

Matthew Nudy, MD, discusses his team's findings on hormone therapy and cardiovascular effects at the 2024 Annual Meeting of the Menopause Society.

Learn how self-advocacy, preparation, and collaboration with doctors can help women gain control over their health and live more fully, free from stigma and shame.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, 23% of patients with breast arterial calcifications on a mammogram had atherosclerotic cardiovascular disease, vs 13.9% without.

Wendie Berg, MD, PhD, explains new breast density reporting standards, cancer risks, and the importance of supplemental imaging for dense breast tissue.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, the prevalence of Alzheimer’s disease was significantly increased among women with prior trauma.

In a recent study, older women with type 2 diabetes had a higher bone mineral density but reduced physical function, linking the reduction in physical function to increased fracture risk in this population.

A recent study found that hormone therapy use in breast cancer patients aged 65 years and older is associated with a reduced risk of Alzheimer's and related dementias.

A recent study found that urinary incontinence does not impact cognitive performance in individuals aged under 70 years old.

A meta-analysis of over 1 million pregnant women in China reveals a 30% anemia prevalence, with significant variations across regions, urban and rural areas, and trimesters.

A systematic review highlights the need for more research on the efficacy of intravenous iron versus red blood cell transfusion for treating severe postpartum anemia.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

An analysis from Harvard shows there is no significantly increased newborn risk when continuing metformin to treat type 2 diabetes in pregnant women.

A recent found that postpartum depression rates do not differ among women treated with intravenous ferric carboxymaltose, intravenous ferric derisomaltose, or oral ferrous sulphate for postpartum anemia.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study found wide disparities in iron deficiency rates among women, influenced by different diagnostic definitions, regardless of race, ethnicity, pregnancy, or age.

A recent study reveals that female Medicare beneficiaries face a significant increase in mortality disparity compared to male beneficiaries, particularly at lower-quality hospitals, underscoring the need for equitable access to high-quality care.

USPSTF now advises biennial breast cancer screening from age 40 to 74 years based on an evolving evidence base.